beta blocking agents	are	drugs
vasodilators	are	drugs
beta blocking agents	treat	hypertension
vasodilators	treat	hypertension
beta blocking agents	reduce	heart rate
vasodilators	dilate	blood vessels
beta blocking agents	block	beta receptors
vasodilators	increase	blood flow
beta blocking agents	contraindicated in	asthma
vasodilators	cause	hypotension
beta blocking agents	interact with	calcium channel blockers
vasodilators	interact with	antihypertensives
beta blocking agents	metabolized in	liver
vasodilators	act on	vascular smooth muscle
beta blocking agents	used for	angina
vasodilators	used for	heart failure
beta blocking agents	adverse effect	bradycardia
vasodilators	adverse effect	headache
beta blocking agents	prescribed for	arrhythmias
vasodilators	prescribed for	pulmonary hypertension
beta blocking agents	include	propranolol
vasodilators	include	nitroglycerin
beta blocking agents	contraindicated in	heart block
vasodilators	contraindicated in	aortic stenosis
beta blocking agents	monitored via	blood pressure
vasodilators	monitored via	heart rate
beta blocking agents	increase	exercise tolerance
vasodilators	decrease	cardiac workload
beta blocking agents	affect	sympathetic nervous system
vasodilators	affect	vascular resistance
beta blocking agents	classified as	cardioselective
vasodilators	classified as	arterial dilators
beta blocking agents	excreted via	kidneys
vasodilators	excreted via	liver
beta blocking agents	require	dose titration
vasodilators	require	blood monitoring
beta blocking agents	combined with	diuretics
vasodilators	combined with	ACE inhibitors
beta blocking agents	caution in	diabetes
vasodilators	caution in	renal impairment
beta blocking agents	mechanism	adrenergic antagonism
vasodilators	mechanism	nitric oxide release
beta blocking agents	brand	Lopressor
vasodilators	brand	Minoxidil
beta blocking agents	pregnancy category	C
vasodilators	pregnancy category	C
beta blocking agents	half-life	3-6 hours
vasodilators	half-life	1-4 hours
beta blocking agents	onset	1 hour
vasodilators	onset	5 minutes
beta blocking agents	duration	12 hours
vasodilators	duration	4 hours
beta blocking agents	absorption	oral
vasodilators	absorption	sublingual
beta blocking agents	protein binding	50%
vasodilators	protein binding	60%
beta blocking agents	metabolism	CYP2D6
vasodilators	metabolism	hepatic
beta blocking agents	excretion	urine
vasodilators	excretion	feces
beta blocking agents	target	beta-1 receptors
vasodilators	target	potassium channels
beta blocking agents	indication	myocardial infarction
vasodilators	indication	erectile dysfunction
beta blocking agents	contraindication	cardiogenic shock
vasodilators	contraindication	phosphodiesterase inhibitors
beta blocking agents	precaution	elderly
vasodilators	precaution	hepatic disease
beta blocking agents	storage	room temperature
vasodilators	storage	dark place
beta blocking agents	solubility	lipophilic
vasodilators	solubility	hydrophilic
beta blocking agents	bioavailability	50%
vasodilators	bioavailability	10%
beta blocking agents	volume of distribution	3 L/kg
vasodilators	volume of distribution	1 L/kg
beta blocking agents	clearance	hepatic
vasodilators	clearance	renal
beta blocking agents	toxicity	bronchospasm
vasodilators	toxicity	reflex tachycardia
beta blocking agents	antidote	glucagon
vasodilators	antidote	norepinephrine
beta blocking agents	first dose effect	hypotension
vasodilators	first dose effect	flushing
beta blocking agents	withdrawal syndrome	rebound hypertension
vasodilators	withdrawal syndrome	angina
beta blocking agents	genetic variation	CYP2D6 poor metabolizers
vasodilators	genetic variation	ALDH2 deficiency
beta blocking agents	drug class	antiarrhythmics
vasodilators	drug class	antihypertensives
beta blocking agents	receptor selectivity	beta-1
vasodilators	receptor selectivity	non-selective
beta blocking agents	clinical trial	mortality reduction
vasodilators	clinical trial	exercise capacity improvement
beta blocking agents	guideline recommendation	first-line
vasodilators	guideline recommendation	adjunct
beta blocking agents	black box warning	abrupt discontinuation
vasodilators	black box warning	hypotension
beta blocking agents	route	intravenous
vasodilators	route	transdermal
